Aminoleban Infusion Soln Special Precautions

Careful Administration: Amino Acids (AMINOLEBAN) should be administered with care in the following patients: Patients with severe acidosis: The patient's clinical condition may be worsened.
Patients with congestive cardiac failure: An increase in the circulating blood volume may worsen the patient's clinical condition.
Patients on dialysis or hemofiltration with serious renal disorder: Urea and other amino acid metabolites may be retained. (See Important Precautions as follows.)
Important Precautions: The volume of urea, etc. removed and accumulated in patients on dialysis or hemofiltration with serious renal disorder varies depending on the dialysis method and patients' conditions. Initiation and continuation of administration should be determined after the patient's conditions are carefully checked based on assessment of blood biochemistry, acid-base equilibrium, and body-fluid balance, etc.
Use in the Elderly: Because elderly patients often have reduced physiological function, it is advisable to consider reducing the dose by decreasing the infusion rate.
Use in Children: The safety in children has not been established (no clinical experience).